Position in BIOA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,410,997
+$4,490,982 QoQ
Shares Held
343,166
+53.1% QoQ
Ownership
0.748%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 151 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $2,153,058,366 across 55 Drug Manufacturers - Specialty & Generic names. BIOA ranks #28 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,542,234 | $398,264,931 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,956,873 | $269,578,854 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
430,844 | $233,444,201 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,259,717 | $212,312,700 | |
| 5 | VTRS |
Viatris Inc
|
10,038,691 | $159,414,410 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,256,056 | $104,741,534 | |
| 7 | ALKS |
Alkermes plc.
|
1,831,619 | $95,976,834 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
818,394 | $90,792,627 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,410,997 | 343,166 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,920,015 | 224,129 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,215,388 | 167,452 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,097,018 | 186,568 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $631,926 | 153,009 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $336,775 | 89,568 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $505,136 | 87,243 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||